ADHD
A neurodevelopmental condition — not a synonym for being distracted
What it is
ADHD (attention-deficit/hyperactivity disorder) is a neurodevelopmental condition characterised by persistent inattention, and/or hyperactivity and impulsivity, that begins in childhood, is present across multiple settings, and causes genuine impairment. Each of those three qualifiers is doing essential work. Everybody is inattentive sometimes; everybody loses their keys and their thread. What distinguishes ADHD is that the difficulties are LIFELONG rather than recent, PERVASIVE rather than confined to one situation, and IMPAIRING rather than merely annoying. It is among the most heritable conditions in psychiatry, it persists into adulthood in a majority of those diagnosed as children, and it presents differently in adults than the hyperactive schoolboy stereotype suggests — most often as internal restlessness, disorganisation, procrastination, emotional dysregulation and chronic underperformance relative to obvious ability.
Why it matters
Because ADHD is both over-claimed and under-diagnosed at the same time, and these are not contradictory — they happen in different populations. Social media has produced a wave of inaccurate self-diagnosis from checklists whose items describe experiences almost everyone has. Simultaneously, ADHD continues to be genuinely missed in adults, and especially in women and girls, whose predominantly inattentive presentation was for decades miscoded as anxiety, as underachievement, or as being 'away with the fairies'. Untreated ADHD carries real cost: educational underachievement, job instability, relationship breakdown, accidents, and substantially elevated rates of substance use disorder. And it is one of the most treatable conditions in psychiatry — the effect size of stimulant medication is larger than that of most treatments in mental health. That combination is what makes accurate assessment worth insisting on, and it is why no supplement belongs anywhere near the front of this page.
What BioSignal knows about treating this
What works for ADHD
BioSignal’s clinical summary, most important first.
- GET A PROPER DIAGNOSTIC ASSESSMENT — ADHD is diagnosed by structured clinical interview establishing childhood onset, pervasiveness and impairment, and by excluding the conditions that mimic it. An online checklist is not an assessment, and treating the wrong condition helps nobody
- RULE OUT THE MIMICS FIRST — chronic sleep deprivation, obstructive sleep apnoea, depression, anxiety, thyroid disease, iron deficiency and substance use all produce inattention that feels identical from the inside. Several are common. All are treatable. Several are missed
- Stimulant medication (methylphenidate, lisdexamfetamine, amfetamines) — the first-line treatment, with an effect size larger than most interventions in psychiatry, and one of the best-evidenced treatments in mental health. It is not a study drug and it is not a personality change: it reduces the core symptoms in most people who genuinely have the condition
- Non-stimulant medication (atomoxetine, guanfacine) where stimulants are unsuitable, ineffective, or not tolerated
- ADHD-specific psychological and skills-based support — for organisation, planning and emotional regulation. It works best ALONGSIDE medication, not instead of it, and the evidence for it as monotherapy in adults is much weaker than for medication
- Workplace and educational accommodations — often the highest-leverage practical change available, and frequently the one nobody mentions
- Treat the co-occurring conditions — anxiety and depression accompany ADHD more often than not, and leaving them untreated undermines everything else
- Sleep, exercise and structure — genuinely helpful adjuncts with real supporting evidence, and not a substitute for treatment of a neurodevelopmental condition
- SUPPLEMENTS, and the honest position on them: omega-3 has a small effect in ADHD that may be real but is a fraction of the size of medication; correcting a DEMONSTRATED iron or vitamin D deficiency is worth doing in its own right; and there is no good evidence that any nootropic, mushroom, or 'focus' formulation treats ADHD. This is last on the list because that is where the evidence puts it
Signal Records relevant to this condition
Interventions and contributing factors — some of these records describe a cause rather than a cure. The rating shown is BioSignal’s confidence in that Signal Record, not a claim about how well it treats this condition. Open any of them for the full evidence.
- Omega-3 Fatty AcidsModerate confidence
Lowers triglycerides, and reduces preterm birth in pregnancy. Routine fish oil does NOT prevent cardiovascular disease, cancer or dementia in the general population. High-dose omega-3 increases atrial fibrillation risk — a real harm most bottles do not mention.
- CaffeineHigh confidence
One of the best-evidenced functional compounds there is: it reliably improves alertness and endurance performance, and it is safe for most healthy adults up to about 400 mg a day. It does not dehydrate you. It does wreck your sleep for far longer than you think.
- L-TheanineLimited evidence
Mild calm alertness; modest attention benefit with caffeine; no durable cognitive enhancement or protection.
- Citicoline (CDP-Choline)Limited evidence
The best-evidenced popular nootropic, but mixed — a modest signal in vascular cognitive impairment, weak evidence in healthy adults, no dementia prevention.
- Alpha-GPCLimited evidence
Weak cognitive-benefit evidence plus an unresolved observational stroke-risk signal — caution outweighs enthusiasm.
- Lion's ManeLimited evidence
Interesting preclinical NGF mechanism; minimal human evidence. Popularity vastly exceeds the evidence base.
- NAD+Limited evidence
The biology is real and the rodent data are striking. Raising NAD+ in humans is demonstrably achievable — and has not yet been shown to produce a meaningful clinical benefit in healthy people. This is a mechanism in search of an outcome.
- MelatoninHigh confidence
A body-clock signal, not a sleeping pill. Genuinely useful for jet lag and circadian rhythm disorders; weak for ordinary insomnia. More is not better — and the doses sold are typically far above what the evidence used.
- AlcoholHigh confidence
A Group 1 carcinogen with dose-dependent harms. The heart-protection belief does not survive the methods designed to test it. Cutting back helps, even without quitting.
New to this? Read these first
How this usually unfolds
- Recognize risk factors
- Get diagnosed
- Track key biomarkers
- Lifestyle first
- Evidence-based treatment
- Long-term monitoring
Who is at risk
- Genetics — ADHD is among the most heritable psychiatric conditions; a first-degree relative with ADHD is the single strongest predictor
- Premature birth and low birth weight
- Prenatal exposures, including maternal smoking and alcohol
- Early childhood traumatic brain injury
- Being female — not a risk factor for HAVING ADHD, but a strong risk factor for it being MISSED
- Presenting as inattentive rather than hyperactive — the quiet, disorganised child is not the one who gets referred
- High cognitive ability, which allows a child to compensate well enough to escape notice, until the demands of adulthood exceed the compensation
How it's diagnosed
ADHD is diagnosed by clinical assessment, not by an online quiz and not by a blood test or a brain scan — no biological test for ADHD exists, and anything sold as one is not diagnostic. A competent assessment establishes three things. That symptoms were present in CHILDHOOD (before age 12), which usually requires historical evidence — school reports, a parent's account — rather than adult recall alone. That they are PERVASIVE, appearing across at least two settings such as work and home, not merely in the one situation you happen to dislike. And that they cause genuine IMPAIRMENT. The assessment must also actively exclude the conditions that mimic ADHD, because several of them are common, treatable, and produce inattention indistinguishable from it from the inside.
Key biomarkers
Lifestyle
Explore this condition across BioSignal
Related Foundations
Related Signal Records
Frequently asked questions
How is ADHD different from just being distracted?
By three things, and the symptoms alone are not among them — because almost everybody has some of the symptoms. First, ONSET: ADHD is neurodevelopmental, so the difficulties are lifelong, present in childhood, not something that began last year. Second, PERVASIVENESS: they show up across settings — at work and at home, not only in the job you hate. Third, IMPAIRMENT: they cause real damage to functioning, not just mild irritation. Losing your keys, procrastinating, and zoning out in meetings are human. ADHD is when a lifelong, cross-situational pattern of these things has meaningfully limited your education, your work, or your relationships.
I saw a checklist on social media and it described me exactly. Do I have ADHD?
Possibly — and the checklist is not what will tell you, because most of those checklists describe experiences that nearly everyone has. That is precisely why they resonate so widely and why they are useless as diagnostic tools. That said, BioSignal is not going to be glib about this. ADHD is genuinely under-diagnosed, particularly in adults and above all in women, and 'everyone thinks they have ADHD now' is a lazy dismissal that has kept a lot of people from help they needed. The honest answer is that recognising yourself in a description is a reason to seek a proper assessment, not a reason to conclude anything, and not a reason to buy a supplement. A structured clinical assessment can tell you. A quiz cannot.
What else can look like ADHD?
A great deal, and this is why assessment matters rather than being bureaucratic box-ticking. Chronic sleep deprivation and untreated obstructive sleep apnoea produce inattention that is indistinguishable from ADHD from the inside. So do depression and anxiety. So does thyroid disease. So does iron deficiency. So do alcohol and cannabis use. So can the effects of trauma. These are common, several are easily tested for, and all of them are treatable — and a person treated for the wrong one of these can lose years. A competent assessment looks for them; a checklist does not.
Do ADHD medications actually work?
Yes — and by the standards of psychiatry, they work remarkably well. Stimulants (methylphenidate, lisdexamfetamine and related drugs) reduce the core symptoms of ADHD in the large majority of people who genuinely have it, with an effect size larger than most treatments in mental health. That is not a marketing claim; it is one of the more consistent findings in the field. They are controlled drugs with real considerations — appetite suppression, sleep disruption, blood pressure and heart rate effects, and a need for monitoring — and they are not a cognitive enhancer for people without ADHD. But the widespread idea that they are a dubious crutch, while a supplement is the 'natural' alternative, has the evidence precisely backwards.
Do supplements help ADHD?
Barely, and BioSignal would rather say that clearly than let you find out by spending money. Omega-3 has a small effect in ADHD that may well be real — it is the best of a weak field — but it is a fraction of the size of medication and it is not a treatment. Correcting a DEMONSTRATED iron or vitamin D deficiency is worth doing for its own sake and may help attention if you were deficient. Beyond that, there is no good evidence that any nootropic, mushroom extract, or 'focus' formulation treats ADHD, and several of the compounds marketed for it have never been tested in ADHD at all. The reason this matters is not the money. It is that ADHD has genuinely effective treatment, and years spent on supplements are years not spent on it.
Can you develop ADHD as an adult?
No — but you can be DIAGNOSED as an adult, and that is a different thing entirely and a far more common story than people realise. ADHD is neurodevelopmental: the symptoms must have been present in childhood, which is why a proper assessment looks for historical evidence. What frequently happens is that a bright or well-supported child compensates well enough to go unnoticed — and then hits a point where the demands exceed the compensation. University, a demanding job, a promotion into management, or becoming a parent. Nothing new appeared. The scaffolding fell away. If the symptoms genuinely began in adulthood, something else is going on, and that is worth finding out about.
Is ADHD over-diagnosed?
Both things are true, and it is worth stating them together rather than picking the one that suits an argument. There is real evidence of over-diagnosis in some settings — for instance, the youngest children in a school year are consistently more likely to be diagnosed than the oldest, which is a diagnosis of relative immaturity, not of ADHD. And there is equally clear evidence of substantial UNDER-diagnosis, particularly in adults, in women and girls, and in people whose presentation is inattentive rather than disruptive. These are not contradictory claims. They are claims about different populations, and the response to both is the same: proper assessment, rather than either a quiz or a dismissal.
Evidence summary
The evidence base for ADHD treatment is unusually strong, and it points in a direction that the supplement market has an interest in obscuring. Stimulant medication has large, consistently replicated effects on core ADHD symptoms in randomized trials, in both children and adults — an effect size that exceeds most interventions in psychiatry. Non-stimulants (atomoxetine, guanfacine) are effective but less so. Psychological and skills-based interventions add value alongside medication; as monotherapy in adults the evidence is considerably weaker. On supplements the picture is thin: omega-3 shows a small effect in meta-analysis that may be genuine but is an order of magnitude away from medication, and no nootropic or 'focus' compound has credible evidence of treating ADHD. Correcting demonstrated iron or vitamin D deficiency is worthwhile on its own terms. Diagnostically, no biological test — blood, EEG, or imaging — is validated for ADHD, and the condition is diagnosed by structured clinical assessment establishing childhood onset, cross-setting pervasiveness, and impairment, with active exclusion of the mimics. The population-level evidence supports BOTH over-diagnosis in some settings (the school-year relative-age effect is robust) and substantial under-diagnosis in adults and in women — findings that are frequently deployed against one another and which are, in fact, about different groups of people.
References & sources
- NICE NG87 — Attention deficit hyperactivity disorder: diagnosis and management
- American Academy of Pediatrics — clinical practice guideline for the diagnosis, evaluation and treatment of ADHD
- European Consensus Statement on diagnosis and treatment of adult ADHD
- Network meta-analyses of pharmacological treatments for ADHD in children, adolescents and adults
- Studies of the relative-age effect in ADHD diagnosis within school year cohorts
- Meta-analyses of omega-3 supplementation in ADHD
Educational information — not medical advice
Is this condition page clear, accurate, and useful? Your feedback shapes what we review next.
Give feedback